Clinical Trial Update: Lipid-lowering Therapy Individualization [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update on lipid-lowering therapy individualization for hypercholesterolemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia

Snippet

Sponsor: Université Catholique de Louvain | Conditions: Hypercholesterolemia | Phase 4 | Status: COMPLETED